|
Code
|
4567D
|
|
MA number
|
16/0225/13-S
|
|
Product Form:
|
plv iio 1x500 U+10 ml solv.(liek.inj.skl.+prísl.)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
National
|
|
MAH, country:
|
Baxalta Innovations GmbH, Austria
|
|
Therapeutic Class:
|
16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
|
|
ATC:
|
| B |
BLOOD AND BLOOD FORMING ORGANS |
| B02 |
ANTIHEMORRHAGICS |
| B02B |
LOCAL HEMOSTATICS, COMBINATIONS |
| B02BD |
Blood coagulation factors |
| B02BD03 |
Factor VIII inhibitor bypassing activity |
|
|
Shelf life:
|
24 |
|
Container:
|
glass vial
|
|
Route of admin.:
|
Intravenous use
|
SPC_FEIBA 50 U_ml_01.2025.pdf
